American Biogenetic Sciences Inc. said Thursday that it hasraised $15.5 million through the exercise of its 3.4 million classB warrants outstanding. The warrants were exercised at $4.50per share.
The stock (NASDAQ:MABXA) closed Thursday at $9.50, up 38cents. After the exercise, the Notre Dame, Ind., company hasabout 13 million shares outstanding and $24 million in workingcapital.
ABS this month filed an investigational new drug applicationwith the FDA to begin human trials of its MH-1 monoclonalantibody to image blood clots.
(c) 1997 American Health Consultants. All rights reserved.